MEG3 and prostate carcinoma: Another preclinical study demonstrated that upregulation of MEG3 in prostate cancer (PCa) cell lines induced apoptosis and G0/G1 phase arrest, to inhibit the expression of Bcl-2 and Cyclin D1.